20th Dec 2018 17:20
Renalytix AI plc
("RenalytixAI" or the "Company")
Director/ PDMR Shareholding
The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 3,168 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 112 pence per share.
Following this purchase, Mr Mills is interested in 9,199,568 Ordinary Shares representing 17.09% of the total voting rights in the Company.
Enquiries:
Renalytix AI plc | www.renalytixai.com | |||
James McCullough, CEO | Via Walbrook PR or Tel: +1 646 397 3970 | |||
|
| |||
N+1 Singer (Nominated Adviser & Broker) | Tel: 020 7496 3000 | |||
Aubrey Powell / James White / George Tzimas (Corporate Finance) |
| |||
Tom Salvesen / Mia Gardner (Corporate Broking) |
| |||
|
| |||
Walbrook PR Limited | Tel: 020 7933 8780 or [email protected] | |||
Paul McManus / Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 | |||
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Harwood Capital LLP (Harwood) as investment manager to North Atlantic Smaller Companies Investment Trust plc and Oryx | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Christopher Mills, non-exec director of the issuer and director of NASCIT and Oryx International Growth Fund Ltd | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Renalytix AI plc | |||
b)
| LEI
| 213800NTOH3FK3WER551
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.25 pence each | |||
|
| ||||
| Identification code | GB00BYWL4Y04
| |||
|
| ||||
b)
| Nature of the transaction
| Share purchase | |||
c)
| Price(s) and volume(s) |
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
| 112.00 pence | 3,168 |
| |
|
|
|
|
| |
d)
| Aggregated information |
| |||
|
| ||||
- Aggregated volume | 3,168 | ||||
|
| ||||
- Price | £3,548.16 | ||||
|
| ||||
e)
| Date of the transaction
| 20 December 2018 | |||
f)
| Place of the transaction
| London Stock Exchange | |||
Related Shares:
Renalytix Plc